The Breakthrough Therapy Designation was granted based on the positive topline results from the Essential3 Phase 3 program in essential ...

Praxis Precision Medicines wants to help meet the large unmet need for effective treatment options. Praxis specializes in ...

Praxis Precision Medicines Inc (NASDAQ: PRAX) stock rose after FDA granted BTD for ulixacaltamide to treat essential tremor.

Patients treated with ulixacaltamide in the parallel-group study (Study 1) showed a mean improvement from baseline in the Modified Activities of Daily Living 11 at Week 8, the pre-specified primary ...

Praxis Precision Medicines has won Food and Drug Administration breakthrough-therapy designation for its ulixacaltamide drug candidate for the treatment of patients with essential tremor.

SEATTLE — About 5% of people over the age of 60 experience essential tremor, a nervous system condition that causes involuntary movements most frequently affecting the hands. “Essentially if you want ...

Shares is Praxis Precision Medicines rose in premarket trading Friday after it said it expects to submit to U.S. regulators a new drug application next year for its investigational drug to treat ...

Q I think I’m coming down with essential tremors, which run in my family. At age 81, my left hand and left leg are making movements that I’m not initiating. My dad died at 95, and because I’m ...

Ben Duncan’s doctor asked him to draw a spiral on a sheet of notebook paper. Tremors sent his hand shaking and scribbling all over the page as he tried to draw. What was left on the paper told the ...

TONIGHT AT 11. NOW TO A HEARTWARMING UPDATE AFTER A LOCAL MAN WENT THROUGH A GROUNDBREAKING MEDICAL PROCEDURE FOR THE ULTRASOUND TREATMENT TARGETS SHAKING HANDS, ALSO KNOWN AS TREMORS. ANGELA ROZIER ...